2-[5-[4-[4-[[(1R)-1-(2-fluorophenyl)ethoxy]carbonylamino]-5-methyl-1,2-oxazol-3-yl]phenyl]tetrazol-2-yl]acetic acid

C22H19FN6O5 — CID 66964572

IUPAC2-[5-[4-[4-[[(1R)-1-(2-fluorophenyl)ethoxy]carbonylamino]-5-methyl-1,2-oxazol-3-yl]phenyl]tetrazol-2-yl]acetic acid
SMILESCc1onc(-c2ccc(-c3nnn(CC(=O)O)n3)cc2)c1NC(=O)O[C@H](C)c1ccccc1F
InChIInChI=1S/C22H19FN6O5/c1-12(16-5-3-4-6-17(16)23)33-22(32)24-19-13(2)34-27-20(19)14-7-9-15(10-8-14)21-25-28-29(26-21)11-18(30)31/h3-10,12H,11H2,1-2H3,(H,24,32)(H,30,31)/t12-/m1/s1
InChIKeyADPLWCGVQKHKEI-GFCCVEGCSA-N
MW466.43 g/mol
LogP3.84
Rot. Bonds7

About 2-[5-[4-[4-[[(1R)-1-(2-fluorophenyl)ethoxy]carbonylamino]-5-methyl-1,2-oxazol-3-yl]phenyl]tetrazol-2-yl]acetic acid

2-[5-[4-[4-[[(1R)-1-(2-fluorophenyl)ethoxy]carbonylamino]-5-methyl-1,2-oxazol-3-yl]phenyl]tetrazol-2-yl]acetic acid (PubChem CID 66964572) has the molecular formula C22H19FN6O5 and a molecular weight of 466.43 g/mol. Its IUPAC name is 2-[5-[4-[4-[[(1R)-1-(2-fluorophenyl)ethoxy]carbonylamino]-5-methyl-1,2-oxazol-3-yl]phenyl]tetrazol-2-yl]acetic acid.

Molecular Properties

Compound Name2-[5-[4-[4-[[(1R)-1-(2-fluorophenyl)ethoxy]carbonylamino]-5-methyl-1,2-oxazol-3-yl]phenyl]tetrazol-2-yl]acetic acid
PubChem CID66964572
Molecular FormulaC22H19FN6O5
Molecular Weight466.43 g/mol
Exact Mass466.14
IUPAC Name2-[5-[4-[4-[[(1R)-1-(2-fluorophenyl)ethoxy]carbonylamino]-5-methyl-1,2-oxazol-3-yl]phenyl]tetrazol-2-yl]acetic acid
SMILESCc1onc(-c2ccc(-c3nnn(CC(=O)O)n3)cc2)c1NC(=O)O[C@H](C)c1ccccc1F
InChIInChI=1S/C22H19FN6O5/c1-12(16-5-3-4-6-17(16)23)33-22(32)24-19-13(2)34-27-20(19)14-7-9-15(10-8-14)21-25-28-29(26-21)11-18(30)31/h3-10,12H,11H2,1-2H3,(H,24,32)(H,30,31)/t12-/m1/s1
InChIKeyADPLWCGVQKHKEI-GFCCVEGCSA-N
XLogP3.84
TPSA145.26 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms34
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500466.43
LogP ≤ 53.84
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Analyze 2-[5-[4-[4-[[(1R)-1-(2-fluorophenyl)ethoxy]carbonylamino]-5-methyl-1,2-oxazol-3-yl]phenyl]tetrazol-2-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[5-[4-[4-[[(1R)-1-(2-fluorophenyl)ethoxy]carbonylamino]-5-methyl-1,2-oxazol-3-yl]phenyl]tetrazol-2-yl]acetic acid?
The IUPAC name of 2-[5-[4-[4-[[(1R)-1-(2-fluorophenyl)ethoxy]carbonylamino]-5-methyl-1,2-oxazol-3-yl]phenyl]tetrazol-2-yl]acetic acid (CID 66964572) is 2-[5-[4-[4-[[(1R)-1-(2-fluorophenyl)ethoxy]carbonylamino]-5-methyl-1,2-oxazol-3-yl]phenyl]tetrazol-2-yl]acetic acid.
What is the SMILES notation for 2-[5-[4-[4-[[(1R)-1-(2-fluorophenyl)ethoxy]carbonylamino]-5-methyl-1,2-oxazol-3-yl]phenyl]tetrazol-2-yl]acetic acid?
The canonical SMILES for 2-[5-[4-[4-[[(1R)-1-(2-fluorophenyl)ethoxy]carbonylamino]-5-methyl-1,2-oxazol-3-yl]phenyl]tetrazol-2-yl]acetic acid is Cc1onc(-c2ccc(-c3nnn(CC(=O)O)n3)cc2)c1NC(=O)O[C@H](C)c1ccccc1F.
What is the InChIKey of 2-[5-[4-[4-[[(1R)-1-(2-fluorophenyl)ethoxy]carbonylamino]-5-methyl-1,2-oxazol-3-yl]phenyl]tetrazol-2-yl]acetic acid?
The InChIKey is ADPLWCGVQKHKEI-GFCCVEGCSA-N. The full InChI is InChI=1S/C22H19FN6O5/c1-12(16-5-3-4-6-17(16)23)33-22(32)24-19-13(2)34-27-20(19)14-7-9-15(10-8-14)21-25-28-29(26-21)11-18(30)31/h3-10,12H,11H2,1-2H3,(H,24,32)(H,30,31)/t12-/m1/s1.
What are the key properties of 2-[5-[4-[4-[[(1R)-1-(2-fluorophenyl)ethoxy]carbonylamino]-5-methyl-1,2-oxazol-3-yl]phenyl]tetrazol-2-yl]acetic acid?
2-[5-[4-[4-[[(1R)-1-(2-fluorophenyl)ethoxy]carbonylamino]-5-methyl-1,2-oxazol-3-yl]phenyl]tetrazol-2-yl]acetic acid has a molecular weight of 466.43 g/mol, XLogP of 3.84, 7 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[5-[4-[4-[[(1R)-1-(2-fluorophenyl)ethoxy]carbonylamino]-5-methyl-1,2-oxazol-3-yl]phenyl]tetrazol-2-yl]acetic acid is sourced from PubChem (CID 66964572), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).